Echiacea purpurea ethanol extract (EPE), rich in alkylamides, cichoric acid, and polyphenols, exhibits potent anti-inflammatory effects through multiple signaling pathways. As a GMP-certified manufacturer, *Blue Eyes Biotech Co., Ltd* provides 4:1 concentrated EPE (standardized to ≥0.5% alkylamides and ≥4% cichoric acid) for pharmaceutical and nutraceutical applications. This study elucidates EPE’s anti-inflammatory mechanisms and presents our high-efficiency extraction process for optimal bioactivity.
1. TLR4/NF-κB Pathway Inhibition
- EPE suppresses LPS-induced TLR4 activation, reducing NF-κB phosphorylation and downstream pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) by 40-60% in macrophages.
- Alkylamides (e.g., dodecatetraenoic acid isobutylamide) selectively bind CB2 cannabinoid receptors, modulating immune responses.
2. ROS/RNS Scavenging
- EPE decreases intracellular ROS/RNS by 50% in inflamed cells via upregulation of SOD and GSH.
- Cichoric acid (≥4%) inhibits iNOS and COX-2 expression, reducing nitric oxide and prostaglandin E2 production.
3. Cytokine Regulation
- In diabetic rat models, EPE (465 mg/kg) lowered TNF-α and IL-1βby 35%, improving oxidative stress-linked inflammation.
- Extraction: Ethanol (40-70%) reflux extraction maximizes alkylamide and polyphenol yield.
- Concentration: Low-temperature vacuum evaporation preserves bioactive compounds, achieving **4:1 potency** (HPLC-verified).
- Quality Control:
- Standardization: ≥0.5% alkylamides, ≥4% cichoric acid.
- Purity: Heavy metals <10 ppm, microbial limits (TAMC <1000 CFU/g).
- Bulk Supply: MOQ 10kg for powder/liquid 4:1 extracts.
- Custom Solutions: Tailored for capsules, topical creams, or injectables.
- Certifications: GMP, ISO 9001, FDA-compliant production.
**Contact Us for Premium EPE Extracts:**
**Email:** [email protected]
**Website:** [www.blueeyes-bio.com](http://www.blueeyes-bio.com)
EPE demonstrates **multi-target anti-inflammatory effects** via TLR4/NF-κB suppression and oxidative stress mitigation. **Blue Eyes Biotech** delivers **high-potency, standardized 4:1 extracts** for global buyers in anti-inflammatory therapeutics.
---
*References: Integrated from clinical and biochemical studies.*